Harvard Catalyst Profiles

University of Arkansas, Fayetteville, AR	BS	2003	Physics
University of Arkansas for Medical Sciences, Little Rock, AR	MD	2007	Medicine
Washington University, St. Louis, MO		2010	Internal Medicine
Harvard Medical School, Boston, MA	MMSc	2014	Patient-oriented research
Brigham and Women's Hospital, Boston, MA		2014	Rheumatology

Our group has an overall focus on using patient-oriented and epidemiologic research studies to evaluate the etiology, outcomes, and public health burden of rheumatic diseases such as rheumatoid arthritis (RA). In particular, we perform studies to evaluate the genetic, environmental, serologic, and familial risk factors for RA, clinical trials for RA prevention, RA outcomes research focusing on the respiratory burden of RA, evaluate the effect of metabolic factors such as weight loss on RA outcomes, and investigate rheumatic manifestations of osseous sarcoidosis. We use large population-based studies for these studies, including the Nurses’ Health Studies, the Studies for the Etiology of RA, the Partners electronic medical record, the Brigham RA Sequential Study, and pharmacy claims databases. We also perform clinical trials including the Personalized Risk Estimator for RA (PRE-RA) Family Study, the Strategy to Prevent the Onset of Clinically-Apparent RA (StopRA), and the Cardiovascular Inflammation Reduction Trial (CIRT).